These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28648863)

  • 1. Two-phase amorphous-amorphous solid drug dispersion with enhanced stability, solubility and bioavailability resulting from ultrasonic dispersion of an immiscible system.
    Martínez LM; Videa M; López Silva T; Castro S; Caballero A; Lara-Díaz VJ; Castorena-Torres F
    Eur J Pharm Biopharm; 2017 Oct; 119():243-252. PubMed ID: 28648863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formation and physical stability of two-phase solid dispersion systems of indomethacin in supercooled molten mixtures with different matrix formers.
    Semjonov K; Kogermann K; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
    Eur J Pharm Sci; 2017 Jan; 97():237-246. PubMed ID: 27890595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
    Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
    Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
    Li Y; Rantanen J; Yang M; Bohr A
    Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
    Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
    Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
    Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
    Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions.
    Huang S; Mao C; Williams RO; Yang CY
    J Pharm Sci; 2016 Dec; 105(12):3549-3561. PubMed ID: 27692620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging.
    Ewing AV; Clarke GS; Kazarian SG
    Eur J Pharm Sci; 2014 Aug; 60():64-71. PubMed ID: 24832964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ball milling and hot-melt extrusion of indomethacin-l-arginine-vinylpyrrolidone-vinyl acetate copolymer: Solid-state properties and dissolution performance.
    Iemtsev A; Zemánková A; Hassouna F; Mathers A; Klajmon M; Slámová M; Malinová L; Fulem M
    Int J Pharm; 2022 Feb; 613():121424. PubMed ID: 34968683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.